Product code

AI devices with FDA product code GXY — Electrode, Cutaneous

Product code GXY (“Electrode, Cutaneous” in openFDA) covers 5 devices on the FDA AI-enabled list, from 4 companies. Most are reviewed by the Neurology panel (5). The most recent decision was myosmart. (13E522); myosmart.cuff (757M20-2); connectgrip. (560X27-1); myosmart trial kit (642V64=T) on April 22, 2026.

5AI devices
4Companies
2018First decision
2026-04-22Latest decision

Trend: devices per year

2018: 12019: 22023: 12026: 1
2018201920232026
AI devices with FDA product code GXY — Electrode, Cutaneous per year: 2018 1, 2019 2, 2023 1, 2026 1

Top companies

All 5 devices, newest first